- Home
- LOCO vs GHRS Comparison
LOCO vs GHRS Comparison
Compare LOCO & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- GHRS
- Stock Information
- Founded
- LOCO 1980
- GHRS 2018
- Country
- LOCO United States
- GHRS Ireland
- Employees
- LOCO N/A
- GHRS N/A
- Industry
- LOCO Restaurants
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- GHRS Health Care
- Exchange
- LOCO Nasdaq
- GHRS Nasdaq
- Market Cap
- LOCO 412.4M
- GHRS 462.0M
- IPO Year
- LOCO 2014
- GHRS 2021
- Fundamental
- Price
- LOCO $11.52
- GHRS $8.99
- Analyst Decision
- LOCO Hold
- GHRS Strong Buy
- Analyst Count
- LOCO 2
- GHRS 3
- Target Price
- LOCO $13.00
- GHRS $35.67
- AVG Volume (30 Days)
- LOCO 161.5K
- GHRS 89.4K
- Earning Date
- LOCO 03-06-2025
- GHRS 02-27-2025
- Dividend Yield
- LOCO N/A
- GHRS N/A
- EPS Growth
- LOCO 0.40
- GHRS N/A
- EPS
- LOCO 0.78
- GHRS N/A
- Revenue
- LOCO $470,971,000.00
- GHRS N/A
- Revenue This Year
- LOCO $2.72
- GHRS N/A
- Revenue Next Year
- LOCO $3.75
- GHRS N/A
- P/E Ratio
- LOCO $14.79
- GHRS N/A
- Revenue Growth
- LOCO N/A
- GHRS N/A
- 52 Week Low
- LOCO $8.17
- GHRS $5.92
- 52 Week High
- LOCO $14.25
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- LOCO 45.76
- GHRS 58.18
- Support Level
- LOCO $11.16
- GHRS $8.02
- Resistance Level
- LOCO $11.86
- GHRS $10.23
- Average True Range (ATR)
- LOCO 0.31
- GHRS 0.90
- MACD
- LOCO 0.05
- GHRS 0.11
- Stochastic Oscillator
- LOCO 67.62
- GHRS 62.20
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.